Intel has partnered with the Michael J. Fox Foundation for Parkinson’s Research to develop an app and wearable device that will analyse and track those who suffer from Parkinson’s disease.
The collaboration will include research studies using a big data analytics platform that will collect information regarding the patient using wearable technology.
The wearable device will be accompanied by an app that will enable patients to record the medications they take, as well as recording their current condition.
Intel hopes that the data produced by the wearable technology will help improve the treatment and research of the disease as well.
Intel Data Center Group senior VP and GM, Diane Bryant, said: "The variability in Parkinson’s symptoms creates unique challenges in monitoring progression of the disease.
"Emerging technologies can not only create a new paradigm for measurement of Parkinson’s, but as more data is made available to the medical community, it may also point to currently unidentified features of the disease that could lead to new areas of research.
Content from our partners
The Michael J. Fox Foundation CEO, Todd Sherer, said: "Nearly 200 years after Parkinson’s disease was first described by Dr. James Parkinson in 1817, we are still subjectively measuring Parkinson’s disease largely the same way doctors did then.
"Data science and wearable computing hold the potential to transform our ability to capture and objectively measure patients’ actual experience of disease, with unprecedented implications for Parkinson’s drug development, diagnosis and treatment."
